Skip to main content
Depressors Pill News
COVID-19 Updates
News

COVID-19 Updates: January 4, 2022

FDA Authorizes Pfizer-BioNTech Booster for 12-15 Year Olds

On Jan 3, 2022, the FDA revised the current emergency use authorization (EUA) for the Pfizer-BioNTech Covid-19 vaccine. This means that anyone aged 12 and over, who completed the 2 dose series of Pfizer-BioNTech, can now get a booster dose. The timeframe for a Pfizer-BioNTech booster is also updated from 6 months to 5 months.

The FDA amended the vaccine’s EUA for certain immunocompromised people ages 5-11 years. This group of patients (e.g. patients who have undergone solid organ transplantation) is now authorized to have a third primary series dose at least 28 days following the second dose of the two-dose series.

Table of available COVID-19 vaccines and their available doses and schedule
Updated vaccine schedules, recommendations, and information
*Click here for additional recommendations for immunocompromised people.
Where can I get a vaccine?

Click here to find where to get vaccinated.

Recommended Resources
Previous Maxor COVID-19 Update
Maxor
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.